Skip to main content
. 2002 Dec 16;99(26):16910–16915. doi: 10.1073/pnas.012679099

Table 1.

Patient ID, APC mutation status, and size of the colorectal adenomas analyzed in this study, as well as analytical methods applied

Patient ID Adenoma ID Germ line APC mutation (nucleotide; codon) Somatic APC mutation (nucleotide; codon) Adenoma size, mm Analytical method
N-1144 249a 502 A>T; R168X 4192 del 2bp; 1398 FS 4 L15/18
249b 502 A>T; R168X 4316 del 1bp; 1439 FS 3.5 L15/18
315 502 A>T; R168X 4132 C>T; Q1371X 5.5 L15/18, FCM, Ki-67
N-1154 203 1495 C>T; R499X 4466 ins 2bp; 1489 FS 4.5 L15/18, FCM, Ki-67
298 1495 C>T; R499X 4393 del 2bp; 1465 FS 8 L15/18, FCM, Ki-67
300 1495 C>T; R499X 4012 C>T; Q1338X 6 L15/18
301 1495 C>T; R499X 4317 del 1bp; 1439 FS 5 L15/18, FCM, Ki-67
312 1495 C>T; R499X 3927 del 5bp; 1309 FS 7.5 L15/18, FCM, Ki-67, CGH
340 1495 C>T; R499X 3916 G>T, E1306X 5 L15/18, FCM, Ki-67
352 1495 C>T; R499X 4348 del 4bp; 1450 FS 5 L15/18, FCM, Ki-67, CGH
240 1495 C>T; R499X 3927 del 5bp; 1309 FS 6.5 L15/18, FCM, Ki-67
243 1495 C>T; R499X 3927 del 5bp; 1309 FS 5.5 L15/18
259 1495 C>T; R499X 4216 C>T; Q1406X 6 L15/18, FCM, Ki-67
264 1495 C>T; R499X 3927 del 5bp; 1309 FS 5 L15/18
350 1495 C>T; R499X 4277 del 1bp; 1426 FS 6 L15/18, FCM, Ki-67
374 1495 C>T; R499X 4466 del 1bp; 1489 FS 5 L15/18, FCM, Ki-67
194b 1495 C>T; R499X 4316 del 1bp; 1439 FS 6 L15/18
N-117 155a 1842 ins 1 bp; 614 FS 4484 ins 1bp; 1495 FS 2.5 L15/18
155b 1842 ins 1 bp; 614 FS 4306 del 13bp; 1436 FS 2.5 L15/18
155c 1842 ins 1 bp; 614 FS 4446 del 10bp; 1482 FS 1 L15/18
N-1263 17 3183 del 5 bp; 1061 FS 4312 del 1bp; 1438 FS 2 L15/18
135b 3183 del 5 bp; 1061 FS 3905 del 1bp; 1302 FS 1.5 L15/18
N-1016 308 3863 del 1bp; 1287 FS LOH 5.5 FCM, Ki-67
N-609 1 3887 ins 13 bp; 1296 FS LOH 3 L15/18
2 3887 ins 13 bp; 1296 FS LOH 3 L15/18
5 3887 ins 13 bp; 1296 FS LOH 3 L15/18
6 3887 ins 13 bp; 1296 FS LOH 3 L15/18
8 3887 ins 13 bp; 1296 FS LOH 3 L15/18
10 3887 ins 13 bp; 1296 FS LOH 3 L15/18
N-1026 258 3907 C>T; Q1303X LOH 4.5 L15/18, FCM, Ki-67
335 3907 C>T; Q1303X LOH 6 L15/18, FCM, Ki-67
N-283 347 3927 del 5bp; 1309 FS LOH 4.5 L15, FCM, Ki-67
N-1066 187 3927 del 5bp; 1309 FS LOH 7 L15/18
N-1633 292 3927 del 5bp; 1309 FS LOH 6 L15/18
N-220 399 3927 del 5bp; 1309 FS LOH 7 FCM, Ki-67
N-127 128a 3927 del 5bp; 1309 FS LOH 5 L15/18
128b 3927 del 5bp; 1309 FS LOH 5 L15/18
128c 3927 del 5bp; 1309 FS LOH 5 L15/18, CGH
129 3927 del 5bp; 1309 FS LOH 1 L15/18, CGH
130 3927 del 5bp; 1309 FS LOH 5 L15/18
131b 3927 del 5bp; 1309 FS LOH 3 L15/18
131c 3927 del 5bp; 1309 FS LOH 3 L15/18, CGH
131d 3927 del 5bp; 1309 FS LOH 3 L15/18
N-907 3 3927 del 5bp; 1309 FS LOH 3 L15/18
5 3927 del 5bp; 1309 FS LOH 3 L15/18
8 3927 del 5bp; 1309 FS LOH 3 L15/18
N-205 206 3927 del 5bp; 1309 FS LOH 1 L15/18
207 3927 del 5bp; 1309 FS LOH 1 L15/18
208 3927 del 5bp; 1309 FS LOH 1 L15/18
209 3927 del 5bp; 1309 FS LOH 1 L15/18
1974/92/B 3927 del 5bp; 1309 FS LOH 11 FCM
N-458 1 3927 del 5bp; 1309 FS LOH 12 FCM
52701 2929-M 3927 del 5bp; 1309 FS LOH 6 FCM
N-610 5 3927 del 5bp; 1309 FS LOH 12.5 FCM
N-351 2 4392 del 2bp; 1464 FS LOH 3 L15/18

L15/18, LOH analysis at chromosomes 15q/18q; FCM, flow cytometry; Ki-67, Ki-67 immunocytochemistry; CGH, comparative genomic hybridization. FS denotes frameshift mutations.